Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaques

Despite incredible scientific efforts, there is no cure for HIV infection. While antiretroviral treatment (ART) can help control the virus and prevent transmission, it cannot eradicate HIV from viral reservoirs established before the initiation of therapy. Further, HIV-infected individuals reliably...

Full description

Saved in:
Bibliographic Details
Published in:npj vaccines 2020-05, Vol.5 (1), p.36-36, Article 36
Main Authors: Blasi, Maria, Wescott, Elizabeth C., Baker, Erich J., Mildenberg, Benjamin, LaBranche, Celia, Rountree, Wes, Haynes, Barton F., Saunders, Kevin O., Moody, M. Anthony, Negri, Donatella, Santra, Sampa, Cara, Andrea, Klotman, Mary E.
Format: Article
Language:English
Subjects:
631/250/255/1901
631/250/590
692/699/255/1901
Antiretroviral agents
Antiretroviral drugs
Antiviral drugs
Biomedical and Life Sciences
Biomedicine
HIV
Human immunodeficiency virus
Immune response
Immunization
Infectious Diseases
Laboratory animals
Medical Microbiology
Monkeys & apes
Public Health
Vaccine
Vaccines
Virology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c498t-4a67e19486c2608ffa67a3064859fff3c4186a15c2968902e231fb5eff62ebac3
cites cdi_FETCH-LOGICAL-c498t-4a67e19486c2608ffa67a3064859fff3c4186a15c2968902e231fb5eff62ebac3
container_end_page 36
container_issue 1
container_start_page 36
container_title npj vaccines
container_volume 5
creator Blasi, Maria
Wescott, Elizabeth C.
Baker, Erich J.
Mildenberg, Benjamin
LaBranche, Celia
Rountree, Wes
Haynes, Barton F.
Saunders, Kevin O.
Moody, M. Anthony
Negri, Donatella
Santra, Sampa
Cara, Andrea
Klotman, Mary E.
description Despite incredible scientific efforts, there is no cure for HIV infection. While antiretroviral treatment (ART) can help control the virus and prevent transmission, it cannot eradicate HIV from viral reservoirs established before the initiation of therapy. Further, HIV-infected individuals reliably exhibit viral rebound when ART is interrupted, suggesting that the host immune response fails to control viral replication in persistent reservoirs. Therapeutic vaccines are one current approach to improving antiviral host immune responses and enhance long term virus control. In the present study, we used an integrase defective lentiviral vector (IDLV) expressing SIV-Gag to boost anti-Gag specific immune responses in macaques chronically infected with the tier-2 SHIV-1157(QNE)Y173H. A single immunization with IDLV-SIV-Gag induced durable (>20 weeks) virus control in 55% of the vaccinated macaques, correlating with an increased magnitude of SIV-Gag specific CD8+ T-cell responses. IDLV-based therapeutic vaccines are therefore an effective approach to improve virus specific CD8+ T-cell responses and mediate virus control.
doi_str_mv 10.1038/s41541-020-0186-5
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7210278</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2404041414</sourcerecordid><originalsourceid>FETCH-LOGICAL-c498t-4a67e19486c2608ffa67a3064859fff3c4186a15c2968902e231fb5eff62ebac3</originalsourceid><addsrcrecordid>eNp9kcFqGzEQhpfS0IQkD9BLEfTSy6YjrbSrvRRK0iYGQw5JcxWyPLIVtJIr7brk7SvjJE0LDXOQhvnmnxn-qnpP4YxCIz9nTgWnNTCogcq2Fm-qIwaiLxmIty_-h9VpzvcAQLu2ER28qw4bxilt-v6oSrdrTHqD0-gM2WpjXNCji4H8cuOazC7md_XN7K6-1CuSME9-zMQFspySXngkW5dwcJqYGMYU_a5k1ikGZ7T3D-TmqrS6YNGMuCSDNvrnhPmkOrDaZzx9fI-rH9-_3Z5f1fPry9n513lteC_Hmuu2Q9pz2RrWgrS25LqBlkvRW2sbw8vVmgrD-lb2wJA11C4EWtsyXGjTHFdf9rqbaTHg0mDZUXu1SW7Q6UFF7dTfleDWahW3qmMUWCeLwKdHgRR3i49qcNmg9zpgnLJiHErQEgX9-A96H6cUynmFkrLrGpD0daoY1HeUQ6HonjIp5pzQPq9MQe2sV3vrVbFe7axXovR8eHnrc8eT0QVgeyCXUlhh-jP6_6q_AVhBuPg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2400097140</pqid></control><display><type>article</type><title>Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaques</title><source>PubMed Central (Open Access)</source><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Blasi, Maria ; Wescott, Elizabeth C. ; Baker, Erich J. ; Mildenberg, Benjamin ; LaBranche, Celia ; Rountree, Wes ; Haynes, Barton F. ; Saunders, Kevin O. ; Moody, M. Anthony ; Negri, Donatella ; Santra, Sampa ; Cara, Andrea ; Klotman, Mary E.</creator><creatorcontrib>Blasi, Maria ; Wescott, Elizabeth C. ; Baker, Erich J. ; Mildenberg, Benjamin ; LaBranche, Celia ; Rountree, Wes ; Haynes, Barton F. ; Saunders, Kevin O. ; Moody, M. Anthony ; Negri, Donatella ; Santra, Sampa ; Cara, Andrea ; Klotman, Mary E.</creatorcontrib><description>Despite incredible scientific efforts, there is no cure for HIV infection. While antiretroviral treatment (ART) can help control the virus and prevent transmission, it cannot eradicate HIV from viral reservoirs established before the initiation of therapy. Further, HIV-infected individuals reliably exhibit viral rebound when ART is interrupted, suggesting that the host immune response fails to control viral replication in persistent reservoirs. Therapeutic vaccines are one current approach to improving antiviral host immune responses and enhance long term virus control. In the present study, we used an integrase defective lentiviral vector (IDLV) expressing SIV-Gag to boost anti-Gag specific immune responses in macaques chronically infected with the tier-2 SHIV-1157(QNE)Y173H. A single immunization with IDLV-SIV-Gag induced durable (&gt;20 weeks) virus control in 55% of the vaccinated macaques, correlating with an increased magnitude of SIV-Gag specific CD8+ T-cell responses. IDLV-based therapeutic vaccines are therefore an effective approach to improve virus specific CD8+ T-cell responses and mediate virus control.</description><identifier>ISSN: 2059-0105</identifier><identifier>EISSN: 2059-0105</identifier><identifier>DOI: 10.1038/s41541-020-0186-5</identifier><identifier>PMID: 32411399</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/250/255/1901 ; 631/250/590 ; 692/699/255/1901 ; Antiretroviral agents ; Antiretroviral drugs ; Antiviral drugs ; Biomedical and Life Sciences ; Biomedicine ; HIV ; Human immunodeficiency virus ; Immune response ; Immunization ; Infectious Diseases ; Laboratory animals ; Medical Microbiology ; Monkeys &amp; apes ; Public Health ; Vaccine ; Vaccines ; Virology</subject><ispartof>npj vaccines, 2020-05, Vol.5 (1), p.36-36, Article 36</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020.</rights><rights>The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c498t-4a67e19486c2608ffa67a3064859fff3c4186a15c2968902e231fb5eff62ebac3</citedby><cites>FETCH-LOGICAL-c498t-4a67e19486c2608ffa67a3064859fff3c4186a15c2968902e231fb5eff62ebac3</cites><orcidid>0000-0002-7084-0406 ; 0000-0002-7091-0312 ; 0000-0003-3340-213X ; 0000-0001-7399-7954</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210278/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2400097140?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25751,27922,27923,37010,37011,44588,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32411399$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Blasi, Maria</creatorcontrib><creatorcontrib>Wescott, Elizabeth C.</creatorcontrib><creatorcontrib>Baker, Erich J.</creatorcontrib><creatorcontrib>Mildenberg, Benjamin</creatorcontrib><creatorcontrib>LaBranche, Celia</creatorcontrib><creatorcontrib>Rountree, Wes</creatorcontrib><creatorcontrib>Haynes, Barton F.</creatorcontrib><creatorcontrib>Saunders, Kevin O.</creatorcontrib><creatorcontrib>Moody, M. Anthony</creatorcontrib><creatorcontrib>Negri, Donatella</creatorcontrib><creatorcontrib>Santra, Sampa</creatorcontrib><creatorcontrib>Cara, Andrea</creatorcontrib><creatorcontrib>Klotman, Mary E.</creatorcontrib><title>Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaques</title><title>npj vaccines</title><addtitle>npj Vaccines</addtitle><addtitle>NPJ Vaccines</addtitle><description>Despite incredible scientific efforts, there is no cure for HIV infection. While antiretroviral treatment (ART) can help control the virus and prevent transmission, it cannot eradicate HIV from viral reservoirs established before the initiation of therapy. Further, HIV-infected individuals reliably exhibit viral rebound when ART is interrupted, suggesting that the host immune response fails to control viral replication in persistent reservoirs. Therapeutic vaccines are one current approach to improving antiviral host immune responses and enhance long term virus control. In the present study, we used an integrase defective lentiviral vector (IDLV) expressing SIV-Gag to boost anti-Gag specific immune responses in macaques chronically infected with the tier-2 SHIV-1157(QNE)Y173H. A single immunization with IDLV-SIV-Gag induced durable (&gt;20 weeks) virus control in 55% of the vaccinated macaques, correlating with an increased magnitude of SIV-Gag specific CD8+ T-cell responses. IDLV-based therapeutic vaccines are therefore an effective approach to improve virus specific CD8+ T-cell responses and mediate virus control.</description><subject>631/250/255/1901</subject><subject>631/250/590</subject><subject>692/699/255/1901</subject><subject>Antiretroviral agents</subject><subject>Antiretroviral drugs</subject><subject>Antiviral drugs</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>HIV</subject><subject>Human immunodeficiency virus</subject><subject>Immune response</subject><subject>Immunization</subject><subject>Infectious Diseases</subject><subject>Laboratory animals</subject><subject>Medical Microbiology</subject><subject>Monkeys &amp; apes</subject><subject>Public Health</subject><subject>Vaccine</subject><subject>Vaccines</subject><subject>Virology</subject><issn>2059-0105</issn><issn>2059-0105</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp9kcFqGzEQhpfS0IQkD9BLEfTSy6YjrbSrvRRK0iYGQw5JcxWyPLIVtJIr7brk7SvjJE0LDXOQhvnmnxn-qnpP4YxCIz9nTgWnNTCogcq2Fm-qIwaiLxmIty_-h9VpzvcAQLu2ER28qw4bxilt-v6oSrdrTHqD0-gM2WpjXNCji4H8cuOazC7md_XN7K6-1CuSME9-zMQFspySXngkW5dwcJqYGMYU_a5k1ikGZ7T3D-TmqrS6YNGMuCSDNvrnhPmkOrDaZzx9fI-rH9-_3Z5f1fPry9n513lteC_Hmuu2Q9pz2RrWgrS25LqBlkvRW2sbw8vVmgrD-lb2wJA11C4EWtsyXGjTHFdf9rqbaTHg0mDZUXu1SW7Q6UFF7dTfleDWahW3qmMUWCeLwKdHgRR3i49qcNmg9zpgnLJiHErQEgX9-A96H6cUynmFkrLrGpD0daoY1HeUQ6HonjIp5pzQPq9MQe2sV3vrVbFe7axXovR8eHnrc8eT0QVgeyCXUlhh-jP6_6q_AVhBuPg</recordid><startdate>20200508</startdate><enddate>20200508</enddate><creator>Blasi, Maria</creator><creator>Wescott, Elizabeth C.</creator><creator>Baker, Erich J.</creator><creator>Mildenberg, Benjamin</creator><creator>LaBranche, Celia</creator><creator>Rountree, Wes</creator><creator>Haynes, Barton F.</creator><creator>Saunders, Kevin O.</creator><creator>Moody, M. Anthony</creator><creator>Negri, Donatella</creator><creator>Santra, Sampa</creator><creator>Cara, Andrea</creator><creator>Klotman, Mary E.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7084-0406</orcidid><orcidid>https://orcid.org/0000-0002-7091-0312</orcidid><orcidid>https://orcid.org/0000-0003-3340-213X</orcidid><orcidid>https://orcid.org/0000-0001-7399-7954</orcidid></search><sort><creationdate>20200508</creationdate><title>Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaques</title><author>Blasi, Maria ; Wescott, Elizabeth C. ; Baker, Erich J. ; Mildenberg, Benjamin ; LaBranche, Celia ; Rountree, Wes ; Haynes, Barton F. ; Saunders, Kevin O. ; Moody, M. Anthony ; Negri, Donatella ; Santra, Sampa ; Cara, Andrea ; Klotman, Mary E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c498t-4a67e19486c2608ffa67a3064859fff3c4186a15c2968902e231fb5eff62ebac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>631/250/255/1901</topic><topic>631/250/590</topic><topic>692/699/255/1901</topic><topic>Antiretroviral agents</topic><topic>Antiretroviral drugs</topic><topic>Antiviral drugs</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>HIV</topic><topic>Human immunodeficiency virus</topic><topic>Immune response</topic><topic>Immunization</topic><topic>Infectious Diseases</topic><topic>Laboratory animals</topic><topic>Medical Microbiology</topic><topic>Monkeys &amp; apes</topic><topic>Public Health</topic><topic>Vaccine</topic><topic>Vaccines</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Blasi, Maria</creatorcontrib><creatorcontrib>Wescott, Elizabeth C.</creatorcontrib><creatorcontrib>Baker, Erich J.</creatorcontrib><creatorcontrib>Mildenberg, Benjamin</creatorcontrib><creatorcontrib>LaBranche, Celia</creatorcontrib><creatorcontrib>Rountree, Wes</creatorcontrib><creatorcontrib>Haynes, Barton F.</creatorcontrib><creatorcontrib>Saunders, Kevin O.</creatorcontrib><creatorcontrib>Moody, M. Anthony</creatorcontrib><creatorcontrib>Negri, Donatella</creatorcontrib><creatorcontrib>Santra, Sampa</creatorcontrib><creatorcontrib>Cara, Andrea</creatorcontrib><creatorcontrib>Klotman, Mary E.</creatorcontrib><collection>SpringerOpen</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Public Health Database (Proquest)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Health Management Database (Proquest)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>npj vaccines</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Blasi, Maria</au><au>Wescott, Elizabeth C.</au><au>Baker, Erich J.</au><au>Mildenberg, Benjamin</au><au>LaBranche, Celia</au><au>Rountree, Wes</au><au>Haynes, Barton F.</au><au>Saunders, Kevin O.</au><au>Moody, M. Anthony</au><au>Negri, Donatella</au><au>Santra, Sampa</au><au>Cara, Andrea</au><au>Klotman, Mary E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaques</atitle><jtitle>npj vaccines</jtitle><stitle>npj Vaccines</stitle><addtitle>NPJ Vaccines</addtitle><date>2020-05-08</date><risdate>2020</risdate><volume>5</volume><issue>1</issue><spage>36</spage><epage>36</epage><pages>36-36</pages><artnum>36</artnum><issn>2059-0105</issn><eissn>2059-0105</eissn><abstract>Despite incredible scientific efforts, there is no cure for HIV infection. While antiretroviral treatment (ART) can help control the virus and prevent transmission, it cannot eradicate HIV from viral reservoirs established before the initiation of therapy. Further, HIV-infected individuals reliably exhibit viral rebound when ART is interrupted, suggesting that the host immune response fails to control viral replication in persistent reservoirs. Therapeutic vaccines are one current approach to improving antiviral host immune responses and enhance long term virus control. In the present study, we used an integrase defective lentiviral vector (IDLV) expressing SIV-Gag to boost anti-Gag specific immune responses in macaques chronically infected with the tier-2 SHIV-1157(QNE)Y173H. A single immunization with IDLV-SIV-Gag induced durable (&gt;20 weeks) virus control in 55% of the vaccinated macaques, correlating with an increased magnitude of SIV-Gag specific CD8+ T-cell responses. IDLV-based therapeutic vaccines are therefore an effective approach to improve virus specific CD8+ T-cell responses and mediate virus control.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>32411399</pmid><doi>10.1038/s41541-020-0186-5</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-7084-0406</orcidid><orcidid>https://orcid.org/0000-0002-7091-0312</orcidid><orcidid>https://orcid.org/0000-0003-3340-213X</orcidid><orcidid>https://orcid.org/0000-0001-7399-7954</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2059-0105
ispartof npj vaccines, 2020-05, Vol.5 (1), p.36-36, Article 36
issn 2059-0105
2059-0105
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7210278
source PubMed Central (Open Access); Publicly Available Content Database (Proquest) (PQ_SDU_P3); Springer Nature - nature.com Journals - Fully Open Access
subjects 631/250/255/1901
631/250/590
692/699/255/1901
Antiretroviral agents
Antiretroviral drugs
Antiviral drugs
Biomedical and Life Sciences
Biomedicine
HIV
Human immunodeficiency virus
Immune response
Immunization
Infectious Diseases
Laboratory animals
Medical Microbiology
Monkeys & apes
Public Health
Vaccine
Vaccines
Virology
title Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaques
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T12%3A55%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapeutic%20vaccination%20with%20IDLV-SIV-Gag%20results%20in%20durable%20viremia%20control%20in%20chronically%20SHIV-infected%20macaques&rft.jtitle=npj%20vaccines&rft.au=Blasi,%20Maria&rft.date=2020-05-08&rft.volume=5&rft.issue=1&rft.spage=36&rft.epage=36&rft.pages=36-36&rft.artnum=36&rft.issn=2059-0105&rft.eissn=2059-0105&rft_id=info:doi/10.1038/s41541-020-0186-5&rft_dat=%3Cproquest_pubme%3E2404041414%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c498t-4a67e19486c2608ffa67a3064859fff3c4186a15c2968902e231fb5eff62ebac3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2400097140&rft_id=info:pmid/32411399&rfr_iscdi=true